Implantable cardioverter defibrillator therapy in pediatric and congenital heart disease patients: a single tertiary center experience in Korea
- PMID: 23559974
- PMCID: PMC3611046
- DOI: 10.3345/kjp.2013.56.3.125
Implantable cardioverter defibrillator therapy in pediatric and congenital heart disease patients: a single tertiary center experience in Korea
Abstract
Purpose: The use of implantable cardioverter defibrillators (ICDs) to prevent sudden cardiac death is increasing in children and adolescents. This study investigated the use of ICDs in children with congenital heart disease.
Methods: This retrospective study was conducted on the clinical characteristics and effectiveness of ICD implantation at the department of pediatrics of a single tertiary center between 2007 and 2011.
Results: Fifteen patients underwent ICD implantation. Their mean age at the time of implantation was 14.5±5.4 years (range, 2 to 22 years). The follow-up duration was 28.9±20.4 months. The cause of ICD implantation was cardiac arrest in 7, sustained ventricular tachycardia in 6, and syncope in 2 patients. The underlying disorders were as follows: ionic channelopathy in 6 patients (long QT type 3 in 4, catecholaminergic polymorphic ventricular tachycardia [CPVT] in 1, and J wave syndrome in 1), cardiomyopathy in 5 patients, and postoperative congenital heart disease in 4 patients. ICD coils were implanted in the pericardial space in 2 children (ages 2 and 6 years). Five patients received appropriate ICD shock therapy, and 2 patients received inappropriate shocks due to supraventricular tachycardia. During follow-up, 2 patients required lead dysfunction-related revision. One patient with CPVT suffered from an ICD storm that was resolved using sympathetic denervation surgery.
Conclusion: The overall ICD outcome was acceptable in most pediatric patients. Early diagnosis and timely ICD implantation are recommended for preventing sudden death in high-risk children and patients with congenital heart disease.
Keywords: Child; Congenital heart defects; Implantable defibrillators; Long QT syndrome.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11. Heart Rhythm. 2014. PMID: 24120999
-
Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest.Eur Heart J. 2019 Sep 14;40(35):2953-2961. doi: 10.1093/eurheartj/ehz309. Eur Heart J. 2019. PMID: 31145795
-
Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review.Heart Rhythm. 2018 Dec;15(12):1791-1799. doi: 10.1016/j.hrthm.2018.06.046. Epub 2018 Jul 3. Heart Rhythm. 2018. PMID: 30063211
-
Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.Europace. 2013 Apr;15(4):523-30. doi: 10.1093/europace/eus388. Epub 2013 Jan 20. Europace. 2013. PMID: 23333943
-
Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.Circ Arrhythm Electrophysiol. 2013 Jun;6(3):562-8. doi: 10.1161/CIRCEP.113.000392. Epub 2013 May 14. Circ Arrhythm Electrophysiol. 2013. PMID: 23673907 Review.
Cited by
-
An Up-to-Date Narrative Review on Congenital Heart Disease Percutaneous Treatment in Children Using Contemporary Devices.Diagnostics (Basel). 2022 May 10;12(5):1189. doi: 10.3390/diagnostics12051189. Diagnostics (Basel). 2022. PMID: 35626343 Free PMC article. Review.
-
Inappropriate ICD Shocks in Pediatric and Congenital Heart Disease Patients.J Innov Card Rhythm Manag. 2017 Nov 15;8(11):2898-2906. doi: 10.19102/icrm.2017.081104. eCollection 2017 Nov. J Innov Card Rhythm Manag. 2017. PMID: 32494433 Free PMC article. Review.
-
Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis.Eur Heart J. 2016 May 7;37(18):1439-48. doi: 10.1093/eurheartj/ehv735. Epub 2016 Feb 11. Eur Heart J. 2016. PMID: 26873095 Free PMC article.
References
-
- Cross BJ, Estes NA, 3rd, Link MS. Sudden cardiac death in young athletes and nonathletes. Curr Opin Crit Care. 2011;17:328–334. - PubMed
-
- Tester DJ, Ackerman MJ. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol. 2007;49:240–246. - PubMed
-
- Kral MA, Spotnitz HM, Hordof A, Bigger JT, Jr, Steinberg JS, Livelli FD., Jr Automatic implantable cardioverter defibrillator implantation for malignant ventricular arrhythmias associated with congenital heart disease. Am J Cardiol. 1989;63:118–119. - PubMed
-
- Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51:1685–1691. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources